glp-1 agonist alcohol GLP1 receptor agonists are supported by preclinical and observational evidence for reducing addictive behaviors, particularly and nicotine use. Initial randomized clinical trials indicate possible reductions in craving and substance intake, though GLP-1 Receptor Agonists Protect the

Samms RJ, Coghlan MP, Sloop KW (2020) How may GIP enhance the therapeutic efficacy of GLP-1

Zhang L, Zhang L, Li L, Holscher C

Liao, R

[DOI] [PubMed] [Google Scholar] 21.Eli Lilly and Company Lillys Mounjaro (Tirzepatide), a GIP/GLP-1 Dual Agonist, Demonstrated Cardiovascular Protection in Landmark Head-to-Head Trial, Reinforcing Its Benefit in Patients with Type 2 Diabetes and Heart Disease

Yokote, N

Since absorption of fat-soluble vitamins and other lipid-dependent nutrients depends on bile acidmediated mechanisms, chronic therapy may reduce effective substrate delivery even when dietary composition appears adequate